]>
IRCT20231030059899N1 IRCT 2024-03-14 Shahid Beheshti University of Medical Sciences Investigating the effect of Quince fruit product for treatment nausea and vomiting of pregnancy. Comparison of the effectiveness of "Quince" (CydoniaOblonga) product and vitamin B6 for treatment nausea and vomiting of pregnancy. 2020-07-22 anticipated 120 Complete https://irct.ir/trial/74166 interventional Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: A simple randomization of the individual has been done, based on the clients, one person will receive the common treatment of vitamin B6 and the next person will be given the fruit product. N/A Hyperemesis Gravidarum. Intervention 1: Control group: patients were given vitamin B6 tablets. Intervention 2: Intervention group: And it was given Quince product to the intervention. Yes - There is a plan to make this available What will be shared: All data can potentially be shared after de-identifying individuals in an Excel file When: This file is now accessible To whom: It will be available for researchers working in academic and scientific institutions. Conditions: Only for scientific purposes and for the production of herbal products Where to obtain: For information, contact Dr. Zahra Torkmani at phone number 09120728852 torkamanizahra330@gmail.com How to obtain: You will be informed as soon as you contact Dr. Torkmani Comments:
public Zahra Torkamani
No. 32, Second Central Ave., Shahid Motahari Ave., Ghanat Kousar
Tehran Iran (Islamic Republic of) 1689914864 +98 21 7738 3261 zahra.torkamani0@yahoo.com Shahid Beheshti University of Medical Sciences scientific professor Saghar Salehpour
Taleghani hospital., Shahid Arabi Ave., Velenjak
Tehran Iran (Islamic Republic of) 1995711151 +98 21 2303 1307 saghar.salehpour2014@gmail.com Shahid Beheshti University of Medical Sciences Iran (Islamic Republic of) Single pregnant woman with a healthy fetus With a gestational age of 6 to 16 weeks With mild to moderate nausea and vomiting Not taking anti emetic medication in the last 48 hours No history of specific disease Literacy for reading and writing 18 years 40 years Female 021.0 Hyperemesis gravidarum, mild or unspecified, starting before the end of the 22nd week of gestation Treatment - Drugs Treatment - Drugs Control group: patients were given vitamin B6 tablets Intervention group: And it was given Quince product to the intervention Severity of nausea and vomiting. Timepoint: Measure improvement over two weeks on days 4 and 11. Method of measurement: Measurement of improvement based on PUQE-24 and severity based on VAS scoring system. Duration of nausea and vomiting. Timepoint: Measure improvement over two weeks on days 4 and 11. Method of measurement: Measurement of improvement based on PUQE-24 and severity based on VAS scoring system. Frequency of vomiting. Timepoint: Measure improvement over two weeks on days 4 and 11. Method of measurement: Measurement of improvement based on PUQE-24 and severity based on VAS scoring system. Frequency of retching. Timepoint: Measure improvement over two weeks on days 4 and 11. Method of measurement: Measurement of improvement based on PUQE-24 and severity based on VAS scoring system. Amount of sleep. Timepoint: Measure improvement over two weeks on days 4 and 11. Method of measurement: Measurement of improvement based on PUQE-24 and severity based on VAS scoring system. Appetite. Timepoint: Measure improvement over two weeks on days 4 and 11. Method of measurement: Measurement of improvement based on PUQE-24 and severity based on VAS scoring system. Shahid Beheshti University of Medical Sciences Approved 2023-10-24 Ethics committee of Shahid Beheshti University of Medical Sciences Shahid Arabi Ave، Velenjak Tehran Tehran Iran (Islamic Republic of)